Article Versions Notes

Albino SL, da Silva Moura WC, Reis MMLd, Sousa GLS, da Silva PR, de Oliveira MGC, Borges TKdS, Albuquerque LFF, de Almeida SMV, de Lima MdCA, et al. ACW-02 an Acridine Triazolidine Derivative Presents Antileishmanial Activity Mediated by DNA Interaction and Immunomodulation. Pharmaceuticals. 2023; 16(2):204. https://doi.org/10.3390/ph16020204

Albino, Sonaly Lima, Willian Charles da Silva Moura, Malu Maria Lucas dos Reis, Gleyton Leonel Silva Sousa, Pablo Rayff da Silva, Mayara Gabriele Carvalho de Oliveira, Tatiana Karla dos Santos Borges, Lucas Fraga Friaça Albuquerque, Sinara Mônica Vitalino de Almeida, Maria do Carmo Alves de Lima, and et al. 2023. "ACW-02 an Acridine Triazolidine Derivative Presents Antileishmanial Activity Mediated by DNA Interaction and Immunomodulation" Pharmaceuticals 16, no. 2: 204. https://doi.org/10.3390/ph16020204

Albino, S. L., da Silva Moura, W. C., Reis, M. M. L. d., Sousa, G. L. S., da Silva, P. R., de Oliveira, M. G. C., Borges, T. K. d. S., Albuquerque, L. F. F., de Almeida, S. M. V., de Lima, M. d. C. A., Kuckelhaus, S. A. S., Nascimento, I. J. d. S., Junior, F. J. B. M., da Silva, T. G., & de Moura, R. O. (2023). ACW-02 an Acridine Triazolidine Derivative Presents Antileishmanial Activity Mediated by DNA Interaction and Immunomodulation. Pharmaceuticals, 16(2), 204. https://doi.org/10.3390/ph16020204